IndraLab
Statements
sparser
"The remaining patients that have neither gene mutation typically have de-regulated kinases including amplification and overexpression of PAK1 [ xref , xref ], inactivation of the NF-1 tumor suppressor [ xref ], loss of NF-1 associated with RAS activation [ xref , xref ] and cell cycle aberrations such as CCND1 and CDK4 amplification [ xref ]."